Kenneth E Kokko
Overview
Explore the profile of Kenneth E Kokko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farnon E, Kokko K, Budge P, Mbaeyi C, Lutterloh E, Qvarnstrom Y, et al.
Clin Infect Dis
. 2016 Jul;
63(7):878-888.
PMID: 27358357
Background: During 2009 and 2010, 2 clusters of organ transplant-transmitted Balamuthia mandrillaris, a free-living ameba, were detected by recognition of severe unexpected illness in multiple recipients from the same donor....
2.
Rodriguez B, Wilhelm A, Kokko K
J Emerg Med
. 2014 Oct;
47(6):635-7.
PMID: 25271183
Background: Intralipid emulsion (ILE) is a nutritional fatty acid supplementation that is emerging as a potential therapy for local anesthetic systemic toxicity and is also being considered as a therapy...
3.
Kuppachi S, Thomas B, Kokko K
Am J Med Sci
. 2013 May;
345(6):482-8.
PMID: 23698093
BK virus, a member of the polyomavirus family, is a well-recognized cause of irreversible graft failure after kidney transplantation. Awareness of the relationship between BK infection and immunosuppression along with...
4.
Nakaya H, Wrammert J, Lee E, Racioppi L, Marie-Kunze S, Nicholas Haining W, et al.
Nat Immunol
. 2011 Jul;
12(8):786-95.
PMID: 21743478
Here we have used a systems biology approach to study innate and adaptive responses to vaccination against influenza in humans during three consecutive influenza seasons. We studied healthy adults vaccinated...
5.
Tumlin J, Roberts B, Kokko K, El Minshawy O, Gooch J
J Pharmacol Exp Ther
. 2009 May;
330(2):602-7.
PMID: 19420299
The addition of calcineurin inhibitors, including cyclosporine A (CsA) and FK-506 (tacrolimus), to transplant protocols has markedly reduced acute allograft rejection and prolonged patient survival. Although monitoring of serum drug...
6.
Gangappa S, Kokko K, Carlson L, Gourley T, Newell K, Pearson T, et al.
Transpl Int
. 2008 Jan;
21(4):293-303.
PMID: 18225995
The growing success of solid organ transplantation poses unique challenges for the implementation of effective immunization strategies. Although live attenuated vaccines have proven benefits for the general population, immunosuppressed patients...
7.
Adams A, Williams M, Jones T, Shirasugi N, Durham M, Kaech S, et al.
J Clin Invest
. 2003 Jun;
111(12):1887-95.
PMID: 12813024
Many strategies have been proposed to induce tolerance to transplanted tissue in rodents; however, few if any have shown equal efficacy when tested in nonhuman primate transplant models. We hypothesized...
8.
Bose A, Inoue Y, Kokko K, Lakkis F
J Immunol
. 2003 Feb;
170(4):1611-4.
PMID: 12574320
Perforin mediates target cell apoptosis by CTLs and NK cells. Although perforin expression correlates strongly with acute allograft rejection, perforin-deficient mice reject allografts with the same kinetics as wild-type recipients....